RxDoctor Payments Data
★ My doctorsLook up a doctor →

Paul McCabe

Worcester, MANPI 1013478239

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,210, 5.7 times the $212 reported in 2023.

$2,374in general payments, 2019–2025

Across 104 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$407
  • AstraZeneca$332
  • Pfizer$304
  • Boehringer Ingelheim$252
  • E.r. Squibb & Sons, L.L.C.$221
  • Medtronic$145
  • plus $712 from 11 others

What the payments were for

  • Food & beverage$2,374100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen20$407
AstraZeneca17$332
Pfizer13$304
Boehringer Ingelheim11$252
E.r. Squibb & Sons, L.L.C.9$221
Medtronic4$145
Kiniksa Pharmaceuticals International, PLC7$128
Abiomed3$117
Alnylam Pharmaceuticals Inc.4$103
Esperion Therapeutics, Inc.4$90
Penumbra, Inc.2$71
Boston Scientific2$53
Lexicon Pharmaceuticals, Inc.2$39
Novartis2$35
Bridgebio Pharma, Inc.2$29
Lantheus Medical Imaging, Inc.1$26
Bayer1$22

Where these figures come from

Is this you, or does something look wrong? →